Remifentanil administration reveals biphasic phMRI temporal responses in rat consistent with dynamic receptor regulation

NeuroImage

Volumn 34, Issue 3, 2007, Pages 1042-1053

  Liu, Christina H ^a,b   Greve, Doug N ^a,b   Dai, Guangping ^a,b   Marota, John J A ^a,b   Mandeville, Joseph B ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; MU OPIATE RECEPTOR AGONIST; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; REMIFENTANIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BRAIN BLOOD VOLUME; BRAIN MAPPING; CAUDATE NUCLEUS; CINGULATE GYRUS; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG RESPONSE; DRUG TARGETING; ENDOCYTOSIS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HYPOTHALAMUS; IN VITRO STUDY; INTERMETHOD COMPARISON; INTERNEURON; MEAN ARTERIAL PRESSURE; NERVE POTENTIAL; NERVE PROJECTION; NEUROTRANSMISSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PHARMACOLOGICAL STIMULATION; PHMRI; PRIORITY JOURNAL; PYRIFORM CORTEX; RAT; REPEATED DRUG DOSE;

ACTION POTENTIALS; ANALGESICS, OPIOID; BRAIN; BRAIN MAPPING; DOSE-RESPONSE RELATIONSHIP, DRUG; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; PIPERIDINES; RECEPTORS, OPIOID, MU;

EID: 33947157292     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2006.10.028     Document Type: Article

References (60)

1. Barzo P., Bari F., Doczi T., Jancso G., and Bodosi M. Significance of the rate of systemic change in blood pressure on the short-term autoregulatory response in normotensive and spontaneously hypertensive rats. Neurosurgery 32 (1993) 611-618
2. Bloom A.S., Hoffmann R.G., Fuller S.A., Pankiewicz J., Harsch H.H., and Stein E.A. Determination of drug-induced changes in functional MRI signal using a pharmacokinetic model. Hum. Brain Mapp. 8 (1999) 235-244
3. Borck C., and Jefferys J.G. Seizure-like events in disinhibited ventral slices of adult rat hippocampus. J. Neurophysiol. 82 (1999) 2130-2142
4. Bowdle T.A. Adverse effects of opioid agonists and agonist-antagonists in anaesthesia. Drug Safety 19 (1998) 173-189
5. Breiter H., Gollub R.L., Weisskoff R.M., Kennedy D., Makris N., Berke J., Goodman J., Kantor H., Gastfriend D., Riorden J., Mathew T., Rosen B., and Hyman S.E. Acute effects of cocaine on human brain activity and emotion. Neuron 19 (1997) 591-611
6. Buerkle H., and Yaksh T.L. Comparison of the spinal actions of the mu-opioid remifentanil with alfentanil and morphine in the rat. Anesthesiology 84 (1996) 94-102
7. Carroll R.C., Beattie E.C., von Zastrow M., and Malenka R.C. Role of AMPA receptor endocytosis in synaptic plasticity. Nat. Rev., Neurosci. 2 (2001) 315-324
8. Chen Y.C., Galpern W.R., Brownell A.L., Mathews R.T., Bogdanov M., Isacson O., Keltner J.R., Beal M.F., Rosen B.R., and Jenkins B.G. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn. Reson. Med. 38 (1997) 389-398
9. Cohen S.R., Kimes A.S., and London E.D. Morphine decreases cerebral glucose utilization in limbic and forebrain regions while pain has no effect. Neuropharmacology 30 (1991) 125-134
10. Di Chiara G., and North R.A. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13 (1992) 185-193
11. Diaz A., Florez J., Pazos A., and Hurle M.A. Opioid tolerance and supersensitivity induce regional changes in the autoradiographic density of dihydropyridine-sensitive calcium channels in the rat central nervous system. Pain 86 (2000) 227-235
12. Drake C.T., and Milner T.A. Mu opioid receptors are in somatodendritic and axonal compartments of GABAergic neurons in rat hippocampal formation. Brain Res. 849 (1999) 203-215
13. Ehlers M.D. Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron 28 (2000) 511-525
14. Friston K.J., Holmes A.P., Worsley K.J., Poline J.P., Frith C.D., and Frackowiak R.S.J. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 2 (1995) 189-210
15. Goodkin H.P., Yeh J.L., and Kapur J. Status epilepticus increases the intracellular accumulation of GABAA receptors. J. Neurosci. 25 (2005) 5511-5520
16. Haidar S.H., Moreton J.E., Liang Z., Hoke J.F., Muir K.T., and Eddington N.D. Evaluating a possible pharmacokinetic interaction between remifentanil and esmolol in the rat. J. Pharm. Sci. 86 (1997) 1278-1282
17. Hamilton J.D. Time Series Analysis (1994), Princeton Univ. Press
18. Hoge R.D., Atkinson J., Gill B., Crelier G.R., Marrett S., and Pike G.B. Linear coupling between cerebral blood flow and oxygen consumption in activated human cortex. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9403-9408
19. Holden M., Hill D.L., Denton E.R., Jarosz J.M., Cox T.C., Rohlfing T., Goodey J., and Hawkes D.J. Voxel similarity measures for 3-D serial MR brain image registration. IEEE Trans. Med. Imag. 19 (2000) 94-102
20. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev., Neurosci. 5 (2004) 347-360
21. James M.K., Feldman P.L., Schuster S.V., Bilotta J.M., Brackeen M.F., and Leighton H.J. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J. Pharmacol. Exp. Ther. 259 (1991) 712-718
22. Johnson L.A., Furman C.A., Zhang M., Guptaroy B., and Gnegy M.E. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation. Neuropharmacology 49 (2005) 750-758
23. Kalisch R., Elbel G.K., Gossl C., Czisch M., and Auer D.P. Blood pressure changes induced by arterial blood withdrawal influence bold signal in anesthetized rats at 7 Tesla: implications for pharmacologic MRI. NeuroImage 14 (2001) 891-898
24. Kneussel M. Dynamic regulation of GABA(A) receptors at synaptic sites. Brain Res. Brain Res. Rev. 39 (2002) 74-83
25. Lambert N.A., Harrison N.L., and Teyler T.J. Evidence for mu opiate receptors on inhibitory terminals in area CA1 of rat hippocampus. Neurosci. Lett. 124 (1991) 101-104
26. Law P.Y., Erickson L.J., El-Kouhen R., Dicker L., Solberg J., Wang W., Miller E., Burd A.L., and Loh H.H. Receptor density and recycling affect the rate of agonist-induced desensitization of mu-opioid receptor. Mol. Pharmacol. 58 (2000) 388-398
27. Leppa M., Korvenoja A., Carlson S., Timonen P., Martinkauppi S., Ahonen J., Rosenberg P.H., Aronen H.J., and Kalso E. Acute opioid effects on human brain as revealed by functional magnetic resonance imaging. NeuroImage 31 (2006) 661-669
28. Leslie R.A., and James M.F. Pharmacological magnetic resonance imaging: a new application for functional MRI. Trends Pharmacol. Sci. 21 (2000) 314-318
29. Lessard A., and Bachelard H. Tonic inhibitory control exerted by opioid peptides in the paraventricular nuclei of the hypothalamus on regional hemodynamic activity in rats. Br. J. Pharmacol. 136 (2002) 753-763
30. Loscher W., and Ebert U. The role of the piriform cortex in kindling. Prog. Neurobiol. 50 (1996) 427-481
31. Mandeville J.B., Marota J.J.A., Kosofsky B.E., Keltner J.R., Weissleder R., Rosen B.R., and Weisskoff R.M. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn. Reson. Med. 39 (1998) 615-624
32. Mandeville J.B., Jenkins B.G., Chen Y.C., Choi J.K., Kim Y.R., Belen D., Liu C., Kosofsky B.E., and Marota J.J. Exogenous contrast agent improves sensitivity of gradient-echo functional magnetic resonance imaging at 9.4 T. Magn. Reson. Med. 52 (2004) 1272-1281
33. Mandeville J.B., Liu C., Kosofsky B.E., and Marota J.J. Transient signal changes in pharmacological fMRI: effects of no interest?. Proc. Int. Soc. Magn. Reson. Med., Miami, FL (2005) 1512
34. Marota J.J.A., Mandeville J.B., Weisskoff R.M., Moskowitz M.A., Rosen B.R., and Kosofsky B.E. Cocaine activation discriminates dopamergic projections by temporal response: an fMRI study in rat. NeuroImage 11 (2000) 13-23
35. McQuiston A.R., and Saggau P. Mu-opioid receptors facilitate the propagation of excitatory activity in rat hippocampal area CA1 by disinhibition of all anatomical layers. J. Neurophysiol. 90 (2003) 1936-1948
36. Mignat C., Wille U., and Ziegler A. Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes. Life Sci. 56 (1995) 793-799
37. Moser M.B., and Moser E.I. Functional differentiation in the hippocampus. Hippocampus 8 (1998) 608-619
38. Neumaier J.F., Mailheau S., and Chavkin C. Opioid receptor-mediated responses in the dentate gyrus and CA1 region of the rat hippocampus. J. Pharmacol. Exp. Ther. 244 (1988) 564-570
39. Panlilio L.V., and Schindler C.W. Self-administration of remifentanil, an ultra-short acting opioid, under continuous and progressive-ratio schedules of reinforcement in rats. Psychopharmacology (Berlin) 150 (2000) 61-66
40. Papatheodoropoulos C., Moschovos C., and Kostopoulos G. Greater contribution of N-methyl-d-aspartic acid receptors in ventral compared to dorsal hippocampal slices in the expression and long-term maintenance of epileptiform activity. Neuroscience 135 (2005) 765-779
41. Patel S.S., and Spencer C.M. Remifentanil. Drugs 52 (1996) 417-427 (discussion 428)
42. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, London
43. Rosow C.E., Moss J., Philbin D.M., and Savarese J.J. Histamine release during morphine and fentanyl anesthesia. Anesthesiology 56 (1982) 93-96
44. Selley D.E., Cao C.C., Sexton T., Schwegel J.A., Martin T.J., and Childers S.R. mu opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine. Biochem. Pharmacol. 62 (2001) 447-455
45. Shah Y.B., Haynes L., Prior M.J., Marsden C.A., Morris P.G., and Chapman V. Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats. Psychopharmacology (Berlin) 180 (2005) 761-773
46. Sotiriou E., Papatheodoropoulos C., and Angelatou F. Differential expression of gamma-aminobutyric acid-a receptor subunits in rat dorsal and ventral hippocampus. J. Neurosci. Res. 82 (2005) 690-700
47. Stefano G.B., Hartman A., Bilfinger T.V., Magazine H.I., Liu Y., Casares F., and Goligorsky M.S. Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J. Biol. Chem. 270 (1995) 30290-30293
48. Sun S.Y., Liu Z., Li P., and Ingenito A.J. Central effects of opioid agonists and naloxone on blood pressure and heart rate in normotensive and hypertensive rats. Gen. Pharmacol. 27 (1996) 1187-1194
49. Tehrani M.H., and Barnes Jr. E.M. Agonist-dependent internalization of gamma-aminobutyric acidA/benzodiazepine receptors in chick cortical neurons. J. Neurochem. 57 (1991) 1307-1312
50. van Rijnsoever C., Sidler C., and Fritschy J.M. Internalized GABA-receptor subunits are transferred to an intracellular pool associated with the postsynaptic density. Eur. J. Neurosci. 21 (2005) 327-338
51. Vaughan C.W., Ingram S.L., Connor M.A., and Christie M.J. How opioids inhibit GABA-mediated neurotransmission. Nature 390 (1997) 611-614
52. Wagner J.J., Caudle R.M., and Chavkin C. Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus. J. Neurosci. 12 (1992) 132-141
53. Wagner K.J., Willoch F., Kochs E.F., Siessmeier T., Tolle T.R., Schwaiger M., and Bartenstein P. Dose-dependent regional cerebral blood flow changes during remifentanil infusion in humans: a positron emission tomography study. Anesthesiology 94 (2001) 732-739
54. Whitcher B., Schwarz A.J., Barjat H., Smart S.C., Grundy R.I., and James M.F. Wavelet-based cluster analysis: data-driven grouping of voxel time courses with application to perfusion-weighted and pharmacological MRI of the rat brain. NeuroImage 24 (2005) 281-295
55. Worsley K.J., Liao C.H., Aston J., Petre V., Duncan G.H., Morales F., and Evans A.C. A general statistical analysis for fMRI data. NeuroImage 15 (2002) 1-15
56. Worsley K.J., Taylor J.E., Tomaiuolo F., and Lerch J. Unified univariate and multivariate random field theory. NeuroImage 23 Suppl. 1 (2004) S189-S195
57. Xi Z.X., Wu G., Stein E.A., and Li S.J. GABAergic mechanisms of heroin-induced brain activation assessed with functional MRI. Magn. Reson. Med. 48 (2002) 838-843
58. Xie C.W., and Lewis D.V. Involvement of cAMP-dependent protein kinase in mu-opioid modulation of NMDA-mediated synaptic currents. J. Neurophysiol. 78 (1997) 759-766
59. Xie C.W., Morrisett R.A., and Lewis D.V. Mu opioid receptor-mediated modulation of synaptic currents in dentate granule cells of rat hippocampus. J. Neurophysiol. 68 (1992) 1113-1120
60. Zaharchuk G., Mandeville J.B., Bogdonov Jr. A.A., Weissleder R., Rosen B.R., and Marota J.J.A. Cerebrovascular dynamics of autoregulation and hypotension: an MRI study of CBF and changes in total and microvascular cerebral blood volume during hemorrhagic hypotension. Stroke 30 (1999) 2197-2205